Skip to main content
Livermore
Livermore
ZHEN

Harpoon Therapeutics, Inc.

HARPDelisted Mar 11, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001708493

Harpoon Therapeutics, Inc. was delisted on Mar 11, 2024; its insiders filed their last Form 4 on Mar 11, 2024; 41 institutions reported holding it in 13F filings for Q4 2023, worth $175.5M in total; no superinvestor held it.

Q2 2022 vs. Q1 2022

How the institutions holding Harpoon Therapeutics, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of HARP: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders79163−15
Shares25.4M3.04K22.7M−2.66M (−10.5%)
Value$128.2M$15.0K$43.4M−$84.7M (−66.1%)

1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (11)

Institutions that held Harpoon Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to HARP in Q2 2022
InstitutionSharesValue% of portfolio
Citadel Advisors LLC129,396$247.0K0.00%
Ergoteles LLC91,900$176.0K0.01%
Marshall Wace, LLP71,743$137.0K0.00%
Acadian Asset Management LLC56,635$109.0K0.00%
Two Sigma Investments, LP19,212$37.0K0.00%
D. E. Shaw & Co., Inc.18,730$36.0K0.00%
Qube Research & Technologies Ltd16,796$32.0K0.00%
HRT Financial LP10,777$20.0K0.00%
Simplex Trading, LLC4,909$9.00K0.00%
Spire Wealth Management1,000$2.00K0.00%
Credit Suisse AG10$00.00%

Sold out (26)

Institutions that held Harpoon Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of HARP in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
International Biotechnology Trust PLC151,445$2.77M
Acuta Capital Partners, LLC497,500$2.47M
Ikarian Capital, LLC117,009$582.0K
DAFNA Capital Management LLC105,163$523.0K
Panagora Asset Management Inc69,736$347.0K
Bank of New York Mellon Corp49,270$245.0K
Nuveen Asset Management, LLC51,037$231.0K
Price T Rowe Associates Inc28,227$140.0K
STRS Ohio25,600$127.0K
Alliancebernstein L.P.23,200$115.0K
Rhumbline Advisers17,240$86.0K
Corton Capital Inc.16,717$83.0K
Connor, Clark & Lunn Investment Management Ltd.14,872$74.0K
Delphia (USA) Inc.11,506$57.0K
Boothbay Fund Management, LLC11,200$56.0K
ExodusPoint Capital Management, LP10,809$54.0K
Deutsche Bank AG10,723$53.0K
American International Group, Inc.9,287$46.0K
California State Teachers Retirement System7,914$39.0K
Allspring Global Investments Holdings, LLC4,891$24.0K
Amalgamated Bank3,045$15.0K
Cutler Group LP2,732$13.0K
Legal & General Group Plc1,977$10.0K
Nisa Investment Advisors, LLC2,000$10.0K
Royal Bank of Canada1,149$6.00K
Ameritas Investment Partners, Inc.1,102$5.00K

Not filed for Q2 2022 yet (1)

Institutions that held Harpoon Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding HARP in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Amalgamated Financial Corp.3,045$15.0K